7 pharma firms facing probe for poor quality drugs funded parties through electoral bonds: Cong
PTI, Mar 21, 2024, 6:26 PM IST
The Congress on Thursday alleged that seven of the 35 pharmaceutical companies which have contributed Rs 1,000 crore to political parties through electoral bonds were being investigated for manufacturing poor quality drugs such as cough syrups and Remdesivir.
Congress general secretary Jairam Ramesh alleged “underhand deals” between the government and the pharmaceutical companies so that they can carry out their businesses after giving donations to the ruling party — “Chanda Do, Dhanda Lo”.
“Thirty-five pharmaceutical companies in India have contributed nearly Rs 1,000 crore to political parties through electoral bonds, data released by the Election Commission on March 14 has revealed. Of these, at least seven companies were being investigated for poor quality drugs when they purchased the bonds. The drugs in question include widely-used products such as cough syrup, blood pressure regulating medicines, and the COVID-19 treatment Remdesivir,” he said in a post on X.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Delhi riots case: HC dismisses plea by Khalid Saifi against attempt to murder charge
States not empowered to take over all private properties for distribution to serve common good: SC
Chhattisgarh NAN ‘scam’: FIR against 2 retired IAS officers, former AG
India, Australia strategic partnership growing steadily: EAM Jaishankar
Rahul Gandhi to attend caste census meeting in Hyderabad today
MUST WATCH
Latest Additions
Bantwal: Theft at Shree Mahalingeshwar temple
Delhi riots case: HC dismisses plea by Khalid Saifi against attempt to murder charge
States not empowered to take over all private properties for distribution to serve common good: SC
Chhattisgarh NAN ‘scam’: FIR against 2 retired IAS officers, former AG
India, Australia strategic partnership growing steadily: EAM Jaishankar
Thanks for visiting Udayavani
You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.